Nano Pharmaceuticals
Market Cap
₹11 ₹11 Cr.
P/E
0.00
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

  • Kobo Biotech
  • Beryl Drugs
  • Link Pharma Chem

FAQs on Kobo Biotech Ltd. Shareprice

Kobo Biotech has given better returns compared to its competitors.
Kobo Biotech has grown at ~50.0% over the last 2yrs while peers have grown at a median rate of -12.04%

There is insufficient historical data to gauge this.
Latest PE of Kobo Biotech is 0

Growth Table

  • Kobo Biotech Ltd.
  • Beryl Drugs
  • Link Pharma Chem

Balance Sheet

  • Kobo Biotech Ltd.
  • Beryl Drugs
  • Link Pharma Chem

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Kobo Biotech Ltd.
  • Beryl Drugs
  • Link Pharma Chem

Cash Flow

  • Kobo Biotech Ltd.
  • Beryl Drugs
  • Link Pharma Chem

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Kobo Biotech Ltd.
  • Beryl Drugs
  • Link Pharma Chem

Quarterly Results

  • Kobo Biotech Ltd.
  • Beryl Drugs
  • Link Pharma Chem

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Kobo Biotech Ltd. Financials

Kobo Biotech balance sheet is weak and might have solvency issues

The net debt of Kobo Biotech is decreasing.
Latest net debt of Kobo Biotech is ₹131 Crs as of Mar-25.
This is less than Mar-24 when it was ₹139 Crs.

The profit is oscillating.
The profit of Kobo Biotech is -₹5.23 Crs for Mar 2025, -₹4.93 Crs for Mar 2024 and -₹5.55 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kobo Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech